For the Inventor, By the Inventor

Enter assignee name

Charlestown, MA, United States of America

Diacrin, Inc.

USPTO Granted Patents = 20

% Expired Patents = 5.0

Forward Citations = 349

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Jonathan H Dinsmore (13 out of 17 patents)

Albert Edge (3 out of 4 patents)

Scott C Chappel (2 out of 29 patents)

4. Robert H Brown, Jr (1 out of 22 patents)

5. Henry F Oettinger (1 out of 1 patent)

6. Albert S B Edge (1 out of 1 patent)

7. Julie Siegan (1 out of 1 patent)

8. Judson Ratliff (1 out of 1 patent)

9. Ole Isacson (1 out of 2 patents)

10. Thomas Fraser (1 out of 1 patent)

11. Wen-Ghih Tsang (1 out of 4 patents)

12. Agatha Zawadzka (1 out of 1 patent)

20 patents: Sort by Forward Citations

1. 6673604 - Muscle cells and their use in cardiac repair (2004-01-06),

2. 6521448 - Porcine MHC class I genes and uses thereof (2003-02-18),

3. 6517833 - Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders (2003-02-11),

4. 6491912 - Porcine cardiomyocytes and their use in treatment of insufficient cardiac function (2002-12-10),

5. 6444205 - Transplantation of neural cells for the treatment of chronic pain or spasticity (2002-09-03),

6. 6432711 - Embryonic stem cells capable of differentiating into desired cell lines (2002-08-13),

7. 6284245 - Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders (2001-09-04),

8. 6277372 - Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases (2001-08-21),

9. 6258353 - Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases (2001-07-10),

10. 6204053 - Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases (2001-03-20),

11. 6140116 - Isolated and modified porcine cerebral cortical cells (2000-10-31),

12. 6096537 - Cells with multiple altered epitopes on a surface antigen for use in (2000-08-01),

13. 5961972 - Isolated porcine pancreatic cells for use in treatment of diseases (1999-10-05),

14. 5919449 - Porcine cardiomyocytes and their use in treatment of insufficient (1999-07-06),

15. 5837236 - Isolated porcine pancreatic cells for use in treatment of diseases (1998-11-17),

Company Overview

Diacrin, Inc. is a biotechnology company based in Charlestown, Massachusetts, specializing in the development of innovative therapies for neurological disorders. The organization focuses on harnessing advanced cellular and molecular technologies to create treatments aimed at addressing unmet medical needs in the field of neurology. With a commitment to scientific excellence, Diacrin is dedicated to advancing research that may lead to transformative solutions for patients suffering from debilitating conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

20 Patents

#1 in Charlestown, MA

#987 in Massachusetts

#16,409 in US

#31,295 in the World

Charlestown, MA, United States of America

Diacrin, Inc.

Forward Citations = 349

12 inventors:

Jonathan H Dinsmore (13 out of 17 patents)

Albert Edge (3 out of 4 patents)

Scott C Chappel (2 out of 29 patents)

4. Robert H Brown, Jr (1 out of 22 patents)

5. Henry F Oettinger (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Diacrin, Inc.. Retrieved from https://idiyas.com/company/diacrin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…